期刊文献+

Visfatin与炎症及胰岛素抵抗研究新进展 被引量:2

Research Progress about Visfatin and Inflammation
下载PDF
导出
摘要 内脏脂肪素(visfatin)是新近发现的主要由内脏脂肪组织表达的一种脂肪细胞因子,与内脏脂肪量呈正相关,在内脏脂肪组织丰度极高,在肥胖的发展过程中表达亦升高。而肥胖是一种非感染性、慢性、全身性炎症病理过程,对于visfatin与炎症的关系研究较少。其可能是机体自身平衡而分泌的一个对抗多种致炎(炎症前)细胞因子,如肿瘤坏死因子α、白细胞介素6的细胞因子,其对糖代谢和visfatinmRNA的表达机制研究提供新思路。 Visfatin is a newly identified adipocytokine which is mainly expressed in visceral fat and has direct correlation with internal organs'fat mass. Adipoeytokine is high in visceral fat, which also has high expression in the development of obesity. Obesity is a chronic systemic inflammatory without infection. There is less study 'about the relationship between visfain and inflammatory. Visfain may be a kind of eytokine secreted for keeping body balance, which can antagonize many proinflammatory factors, such as TNF-α, IL-6 and so on. It also provide a new ideas for studying glyeometabolism and the expression of vislatin mRNA.
出处 《医学综述》 2008年第4期503-505,共3页 Medical Recapitulate
关键词 胰岛素抵抗 内脏脂肪素 炎症 前B细胞克隆增强因子 内脏脂肪 肥胖 Insulin resistance Visfatin Inflammatory Pre-B cell colony-enhancing factor Visceral fat Obesity
  • 相关文献

参考文献1

二级参考文献11

  • 1C. A. Curat,V. Wegner,C. Sengenès,A. Miranville,C. Tonus,R. Busse,A. Bouloumié.Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin[J].Diabetologia.2006(4)
  • 2Chae GN,Kwak SJ.NF-κB is involved in the TNF-α induced inhibition of the differentiation of 3T3-L1 cells by reducing PPARγ expression[].Experimental and Molecular Medicine.2003
  • 3.
  • 4Maslowska M,Sniderman AD,Germinario R,Cianflone K.ASP stimulates glucose transport in cultured human adipocytes[].International Journal of Obesity.1997
  • 5Fantuzzi G.Adipose tissue, adipokines and inflammation[].The Journal of Allergy and Clinical Immunology.2005
  • 6Koutsari C,Jensen MD.Free fatty acid metabolism in human obesity[].Journal of Lipid Research.2006
  • 7Rennie KL,Jebb SA.Prevalence of obesity in GreatBritain[].Obesity Reviews.2005
  • 8Maslowska M,Wang HW,Cianflone K.Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence[].Vitamins and Hormones.2005
  • 9Faraj M,Lu HL,Cianflone K.Diabetes, lipids, and adipocyte secretagogues[].Biochemistry and Cell Biology.2004
  • 10Gaster M,Rustan AC,Beck-Nielsen H.Differential utilization of saturated Palmitate and unsaturated oleate: evidence from cultured myotubes[].Diabetes.2005

共引文献21

同被引文献81

  • 1龙艳,苏珂,于健,胡永玲.瘦素、肿瘤坏死因子与2型糖尿病患者胰岛素抵抗的关系[J].四川大学学报(医学版),2004,35(4):580-581. 被引量:5
  • 2刘玲,胡国平,王佑民,杨明功.肥胖患者血清瘦素、TNF-α、游离脂肪酸水平与胰岛素敏感性的相关性研究[J].安徽医学,2005,26(6):460-462. 被引量:7
  • 3李伶,杨刚毅,方超,张凌,李清明,李钶,孙勤,张兴渝,庞久高,唐毅,Guenther Boden.高脂喂养和脂质诱导的胰岛素抵抗大鼠糖代谢、抵抗素和脂联素的变化[J].中国糖尿病杂志,2007,15(3):142-145. 被引量:5
  • 4Himsworth H P.Diabetes mellitus:its differentiation into insulin-sensitive and insulin insensitive types.Lancet,1936;1:127-130.
  • 5Zimmerman T,Horber F,Rodriguez N,et al.Contribution of insulin resistance to catabolic effect of prednisone on leucine metabolism in humans.Diabetes,1989;38(10):1238-1244.
  • 6Liang L,Guo W H,Esquiliano D R.Insulin-like growth factor 2 and the insulin receptor,but not insulin regulate fetal hepatic glycogenSynthesis.Endocrinology,2010;151(2):741-747.
  • 7Macheda M L,Rogers S,Best J D.Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer.J Cell Physiol,2005;202(3):654-662.
  • 8Bonadonna R C,Prato S,Sacomani M P,et al.Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.J Clin Invest,1993 ;92(1):486-494.
  • 9Kelley D E,Minton M A,Watkins S C,et al.The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.J Clin Invest,1996;97(12):2705-2713.
  • 10James D E,Brown R,Navarro J,et al.Insulin-rugulatable tissues express a unique insulin-sensitive glucose transport protein.Nature,1988;333(6169):183-185.

引证文献2

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部